GGrantIndex
Sort

3,198 grants matching mrna vaccine

Development of an mRNA-Based Therapeutic HIV/AIDS Vaccine

$850,670
Afamefuna Okoye · Oregon Health & Science University · R01 · FY2020 · AI

Developing Durable, Env-Boosted CAR T Cells for HIV Cure

$849,858
Christopher W Peterson · Fred Hutchinson Cancer Center · R01 · FY2024 · AI

Optimization of SOSIP Nanoparticle and mRNA Immunogens to Elicit V3 Glycan bNAbs in Rhesus Macaques

$849,354
Mark Lewis · Bioqual, Inc. · N01 · FY2024 · AI

Poxvirus Gene Expression and DNA Replication

$848,411
Bernard Moss · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI

Diet and Duration of Cervical HPV Infection

$848,006
University Of Hawaii At Manoa · R01 · FY2005 · CA

Understanding Unconventional CD8+ T cell Responses in Protection from HIV

$847,205
Jonah B. Sacha · Oregon Health & Science University · R01 · FY2018 · AI

Vaccine Development Of Nontypeable Haemophilus influenzae/Moraxella catarrhalis

$846,275
Xin-Xing Xing Gu · National Institute On Deafness And Other Communication Disorders · ZIA · FY2009 · DC

Development of novel HIV Env vaccines to augment B lymphocyte responses via delivery of stabilized well-ordered Env spikes for comparative evaluation in preclinical immunogenicity and efficacy studies

$845,995
Christopher Parks · International Aids Vaccine Initiative · P01 · FY2016 · AI

Development testing of nucleic acid-based vaccine for HIV other indications

$845,848
Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

PROJECT TITLE: FURTHER EVALUATION OF AMHR2-ED ANTIGENS FOR EPITHELIAL OVARIAN CARCINOMA

$845,841
Chinthalapally Rao · University Of Oklahoma Hlth Sciences Ctr · N01 · FY2021 · CA

Host Immune Responses to Antigens of Malaria Parasites

$845,075
Carole Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI

Rational design and evaluation of novel mRNA vaccines against MERS-CoV

$844,900
Lanying Du · New York Blood Center · R01 · FY2018 · AI

Development of an mRNA-Based Therapeutic HIV/AIDS Vaccine

$844,491
Afamefuna Okoye · Oregon Health & Science University · R01 · FY2021 · AI

Development of Viral Vaccines against Sarbecoviruses and Merbecoviruses

$844,055
Michael S. Diamond · Washington University · P01 · FY2025 · AI

Development of novel lipid nanoparticles for nucleic acids delivery in the brain

$843,806
Yizhou Dong · Icahn School Of Medicine At Mount Sinai · U01 · FY2025 · EB

A new humanized mouse model to study HBV gene editing

$843,440
Keith R Jerome · Fred Hutchinson Cancer Center · R01 · FY2025 · AI

An improved low-endotoxin Clean Genome E. coli strain for production of biological products

$842,151
David A Frisch · Scarab Genomics, Llc · R44 · FY2024 · GM

Nucleoside modified mRNA based HIV vaccine

$842,141
Drew Weissman · University Of Pennsylvania · R01 · FY2017 · AI

Exploring the membrane-related components of HIV-1 Env for immunogen design

$841,863
Bing Chen · Boston Children'S Hospital · R01 · FY2023 · AI

Development of mRNA-platform vaccines

$841,516
Fredrick Heath Damron · West Virginia University · R01 · FY2023 · AI

Development of an mRNA-Based Therapeutic HIV/AIDS Vaccine

$840,477
Afamefuna Okoye · Oregon Health & Science University · R01 · FY2023 · AI

Lysine Acetylation in N. gonorrhoeae Quorum Sensing and Biofilm Formation

$839,372
John R Kirby · Medical College Of Wisconsin · R01 · FY2017 · AI

Nucleoside modified mRNA based HIV vaccine

$839,218
Drew Weissman · University Of Pennsylvania · R01 · FY2018 · AI

Diet and Duration of Cervical HPV Infection

$836,697
Marc T Goodman · University Of Hawaii At Manoa · R01 · FY2007 · CA

Cytokines in AIDS and Cancer

$836,568
George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA